Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Psycheceutical Bioscience, Inc.

Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Tickers BWVI
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Tickers BWVI
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Tickers BWVI
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Tickers BWVI
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Tickers BWVI
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Tickers BWVI
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Tickers BWVI
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Tickers BWVI
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council
From Psycheceutical Bioscience, Inc.
Via GlobeNewswire
Tickers BWVI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.